pushpa-itagi
Post-doctoral research fellow, Fred Hutchinson Cancer Center, Dr. Gavin Ha and Dr. Andrew Hsieh labs
Fred Hutchinson Cancer CenterSeattle
Pinned Repositories
SigProfilerAssignment
Assignment of known mutational signatures to individual samples and individual somatic mutations
Meltos
Meltos: Multi-Sample Tumor Phylogeny Reconstruction for Structural Variants
Griffin
A flexible framework for nucleosome profiling of cell-free DNA
lichee
Multi-sample cancer phylogeny reconstruction
pairtree
Pairtree is a method for reconstructing cancer evolutionary history in individual patients, and analyzing intratumor genetic heterogeneity. Pairtree focuses on scaling to many more cancer samples and cancer cell subpopulations than other algorithms, and on producing concise and informative interactive characterizations of posterior uncertainty.
pyclone-vi
Fast method for inferring cancer clonal population structure from SNV data.
SigProfilerAssignment
Assignment of known mutational signatures to individual samples and individual somatic mutations
TitanCNA
Analysis of subclonal copy number alterations (CNA) and loss of heterozygosity (LOH) in cancer
3UTRMutationalMPRA
pushpa-itagi's Repositories
pushpa-itagi/Griffin
A flexible framework for nucleosome profiling of cell-free DNA
pushpa-itagi/lichee
Multi-sample cancer phylogeny reconstruction
pushpa-itagi/pairtree
Pairtree is a method for reconstructing cancer evolutionary history in individual patients, and analyzing intratumor genetic heterogeneity. Pairtree focuses on scaling to many more cancer samples and cancer cell subpopulations than other algorithms, and on producing concise and informative interactive characterizations of posterior uncertainty.
pushpa-itagi/pyclone-vi
Fast method for inferring cancer clonal population structure from SNV data.
pushpa-itagi/SigProfilerAssignment
Assignment of known mutational signatures to individual samples and individual somatic mutations
pushpa-itagi/TitanCNA
Analysis of subclonal copy number alterations (CNA) and loss of heterozygosity (LOH) in cancer